{"pmid":32293518,"title":"Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series.","text":["Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series.","Crit Care","Zeng, Yingchun","Cai, Zhongxiang","Xianyu, Yunyan","Yang, Bing Xiang","Song, Ting","Yan, Qiaoyuan","32293518"],"journal":"Crit Care","authors":["Zeng, Yingchun","Cai, Zhongxiang","Xianyu, Yunyan","Yang, Bing Xiang","Song, Ting","Yan, Qiaoyuan"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32293518","week":"202016|Apr 13 - Apr 19","doi":"10.1186/s13054-020-2840-8","source":"PubMed","topics":["Treatment","Diagnosis"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664266295824089089,"score":8.233237,"similar":[{"pmid":32251794,"title":"Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?","text":["Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged since December 2019 in Wuhan city, and has quickly spread throughout China and other countries. To date, no specific treatment has been proven to be effective for SARS-CoV-2 infection. According to World Health Organization (WHO), management of coronavirus disease 19 (COVID-19) has mainly focused on infection prevention, case detection and monitoring, and supportive care. Given to the previous experience, extracorporeal membrane oxygenation (ECMO) has been proven to be an effective therapy in the treatment of respiratory failure or acute respiratory distress syndrome (ARDS). On the basis of similar principle, ECMO may be also an effective therapy in the treatment of severe COVID-19. In this study, we described and discussed the clinical outcomes of ECMO for ARDS patients, ECMO use for severe COVID-19 in China, the indications of ECMO use, and some important issues associated with ECMO.","Int J Infect Dis","Hong, Xiaoyang","Xiong, Jing","Feng, Zhichun","Shi, Yuan","32251794"],"abstract":["The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged since December 2019 in Wuhan city, and has quickly spread throughout China and other countries. To date, no specific treatment has been proven to be effective for SARS-CoV-2 infection. According to World Health Organization (WHO), management of coronavirus disease 19 (COVID-19) has mainly focused on infection prevention, case detection and monitoring, and supportive care. Given to the previous experience, extracorporeal membrane oxygenation (ECMO) has been proven to be an effective therapy in the treatment of respiratory failure or acute respiratory distress syndrome (ARDS). On the basis of similar principle, ECMO may be also an effective therapy in the treatment of severe COVID-19. In this study, we described and discussed the clinical outcomes of ECMO for ARDS patients, ECMO use for severe COVID-19 in China, the indications of ECMO use, and some important issues associated with ECMO."],"journal":"Int J Infect Dis","authors":["Hong, Xiaoyang","Xiong, Jing","Feng, Zhichun","Shi, Yuan"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32251794","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.ijid.2020.03.058","keywords":["acute respiratory distress syndrome","coronavirus disease 19","extracorporeal membrane oxygenation","respiratory failure"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1663352136203763712,"score":138.26775},{"pmid":32074258,"title":"Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation.","text":["Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation.","JAMA","MacLaren, Graeme","Fisher, Dale","Brodie, Daniel","32074258"],"journal":"JAMA","authors":["MacLaren, Graeme","Fisher, Dale","Brodie, Daniel"],"date":"2020-02-20T11:00:00Z","year":2020,"_id":"32074258","week":"20208|Feb 17 - Feb 23","doi":"10.1001/jama.2020.2342","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663352134601539586,"score":130.12009},{"pmid":32285929,"title":"Extracorporeal membrane oxygenation in COVID-19.","text":["Extracorporeal membrane oxygenation in COVID-19.","Cardiol J","Smereka, Jacek","Puslecki, Mateusz","Ruetzler, Kurt","Filipiak, Krzysztof J","Jaguszewski, Milosz","Ladny, Jerzy R","Szarpak, Lukasz","32285929"],"journal":"Cardiol J","authors":["Smereka, Jacek","Puslecki, Mateusz","Ruetzler, Kurt","Filipiak, Krzysztof J","Jaguszewski, Milosz","Ladny, Jerzy R","Szarpak, Lukasz"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32285929","week":"202016|Apr 13 - Apr 19","doi":"10.5603/CJ.a2020.0053","keywords":["COVID-19","ECMO","extracorporeal membrane oxygenation","pneumonia","treatment"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664071627195809794,"score":124.07672},{"pmid":32301347,"title":"Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic.","text":["Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic.","Future Cardiol","Pravda, Nili Schamroth","Pravda, Miri Schamroth","Kornowski, Ran","Orvin, Katia","32301347"],"journal":"Future Cardiol","authors":["Pravda, Nili Schamroth","Pravda, Miri Schamroth","Kornowski, Ran","Orvin, Katia"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32301347","week":"202016|Apr 13 - Apr 19","doi":"10.2217/fca-2020-0040","keywords":["covid-19","ecmo","extracorporeal membrane oxygenation therapy"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664357978615054336,"score":111.60295},{"pmid":32243266,"title":"Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, China.","text":["Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, China.","Severe cases of coronavirus disease 2019 (COVID-19) cannot be adequately managed with mechanical ventilation alone. The role and outcome of extracorporeal membrane oxygenation (ECMO) in the management of COVID-19 is currently unclear. Eight COVID-19 patients have received ECMO support in Shanghai with 7 with VV ECMO support and 1 VA ECMO during cardiopulmonary resuscitation. As of March 25, 2020, 4 patients died (50% mortality), three patients (37.5%) were successfully weaned off ECMO after 22, 40 days and 47 days support respectively, but remain on mechanical ventilation. One patient is still on VV ECMO with mechanical ventilation.The PaO2/FiO2 ratio before ECMO initiation were between 54 to 76 and all were well below 100. The duration of mechanical ventilation before ECMO ranged from 4-21 days. Except the one emergent VA ECMO during cardiopulmonary resuscitation, other patients were on ECMO support for between 18 to 47 days. In conclusion, ensuring effective, timely, and safe ECMO support in COVID-19 is key to improving clinical outcomes. ECMO support might be an integral part of the critical care provided for COVID-19 patients in centers with advanced ECMO expertise.","ASAIO J","Li, Xin","Guo, Zhen","Li, Bailing","Zhang, Xiaolin","Tian, Rui","Wu, Wei","Zhang, Zhongwei","Lu, Yunfei","Chen, Nan","Clifford, Sean P","Huang, Jiapeng","32243266"],"abstract":["Severe cases of coronavirus disease 2019 (COVID-19) cannot be adequately managed with mechanical ventilation alone. The role and outcome of extracorporeal membrane oxygenation (ECMO) in the management of COVID-19 is currently unclear. Eight COVID-19 patients have received ECMO support in Shanghai with 7 with VV ECMO support and 1 VA ECMO during cardiopulmonary resuscitation. As of March 25, 2020, 4 patients died (50% mortality), three patients (37.5%) were successfully weaned off ECMO after 22, 40 days and 47 days support respectively, but remain on mechanical ventilation. One patient is still on VV ECMO with mechanical ventilation.The PaO2/FiO2 ratio before ECMO initiation were between 54 to 76 and all were well below 100. The duration of mechanical ventilation before ECMO ranged from 4-21 days. Except the one emergent VA ECMO during cardiopulmonary resuscitation, other patients were on ECMO support for between 18 to 47 days. In conclusion, ensuring effective, timely, and safe ECMO support in COVID-19 is key to improving clinical outcomes. ECMO support might be an integral part of the critical care provided for COVID-19 patients in centers with advanced ECMO expertise."],"journal":"ASAIO J","authors":["Li, Xin","Guo, Zhen","Li, Bailing","Zhang, Xiaolin","Tian, Rui","Wu, Wei","Zhang, Zhongwei","Lu, Yunfei","Chen, Nan","Clifford, Sean P","Huang, Jiapeng"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243266","week":"202014|Mar 30 - Apr 05","doi":"10.1097/MAT.0000000000001172","source":"PubMed","locations":["Shanghai","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1663352135763361795,"score":108.34131}]}